47 related articles for article (PubMed ID: 24069190)
1. Association between endothelin-1 and systemic lupus erythematosus: insights from a case-control study.
Li R; Yang C; Tang YY; Wang DC; Xu WD; Huang AF
Sci Rep; 2023 Sep; 13(1):15970. PubMed ID: 37749230
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma.
Mirabello L; Yu K; Berndt SI; Burdett L; Wang Z; Chowdhury S; Teshome K; Uzoka A; Hutchinson A; Grotmol T; Douglass C; Hayes RB; Hoover RN; Savage SA;
BMC Cancer; 2011 May; 11():209. PubMed ID: 21619704
[TBL] [Abstract][Full Text] [Related]
3. Influence of Different Evolutive Forces on
Flore L; Francalacci P; Massidda M; Robledo R; Calò CM
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895244
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Endothelial Dysfunction to Cancer Susceptibility and Progression: A Comprehensive Narrative Review on the Genetic Risk Component.
de Melo IG; Tavares V; Pereira D; Medeiros R
Curr Issues Mol Biol; 2024 May; 46(5):4845-4873. PubMed ID: 38785560
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma.
Muñoz-Garcia J; Vargas-Franco JW; Royer BB; Cochonneau D; Amiaud J; Heymann MF; Heymann D; Lézot F
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406536
[TBL] [Abstract][Full Text] [Related]
6. ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway.
Yin H; Wang L; Li F; Wang D; Zhang Z; Yu B; Liu Y
Transl Cancer Res; 2020 May; 9(5):3282-3292. PubMed ID: 35117695
[TBL] [Abstract][Full Text] [Related]
7. Genetic Relationship Between Endothelin-1 Gene Polymorphisms and Intracerebral Hemorrhage Among Chinese Han People.
Zhang W; Zhao W; Ge C; Li X; Yang X; Xiang Y; Sun Z
Med Sci Monit; 2020 Mar; 26():e919110. PubMed ID: 32168316
[TBL] [Abstract][Full Text] [Related]
8. The endothelin 1 and endothelin receptor A gene polymorphisms increase the risk of developing papillary thyroid cancer.
Aydin AF; Vural P; Doğru-Abbasoğlu S; Çil E
Mol Biol Rep; 2019 Feb; 46(1):199-205. PubMed ID: 30411193
[TBL] [Abstract][Full Text] [Related]
9. The Evaluation of Endothelin-1 and Endothelin Receptor Type A Gene Polymorphisms in Patients with Vitiligo.
Bingül İ; Aydıngöz İE; Vural P; Doğru-Abbasoğlu S; Uysal M
Indian J Dermatol; 2016; 61(1):118. PubMed ID: 26955120
[TBL] [Abstract][Full Text] [Related]
10. The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.
Neumann ZL; Pondenis HC; Masyr A; Byrum ML; Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(6):1584-94. PubMed ID: 26426813
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis.
Panoulas VF; Douglas KM; Smith JP; Taffé P; Stavropoulos-Kalinoglou A; Toms TE; Elisaf MS; Nightingale P; Kitas GD
Endothelium; 2008; 15(4):203-12. PubMed ID: 18663623
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in Endothelin-1 Gene: An Overview.
Ahmed M; Rghigh A
Curr Clin Pharmacol; 2016; 11(3):191-210. PubMed ID: 27397091
[TBL] [Abstract][Full Text] [Related]
13. From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma.
Dean DC; Shen S; Hornicek FJ; Duan Z
Cancer Metastasis Rev; 2018 Dec; 37(4):719-731. PubMed ID: 30167827
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 single nucleotide polymorphisms and risk of pulmonary metastatic osteosarcoma.
Zang X; Zhou Y; Huang Z; Zhang C
PLoS One; 2013; 8(9):e73349. PubMed ID: 24069190
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 gene polymorphisms and risk of chemoresistant pediatric osteosarcoma.
Zhou Y; Liu B; Wang M; Ni J
Pediatr Blood Cancer; 2014 Apr; 61(4):612-7. PubMed ID: 24123836
[TBL] [Abstract][Full Text] [Related]
16. Association of endothelin-1 gene single-nucleotide polymorphisms and haplotypes with risk of hormone refractory prostate cancer.
Xu D; Wang X; Lou Y
Pharmazie; 2017 Feb; 72(2):103-106. PubMed ID: 29441862
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
